Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
1,414,320
-
Share change
-
+447,175
-
Total reported value
-
$20,576,000
-
Price per share
-
$14.55
-
Number of holders
-
14
-
Value change
-
+$6,504,572
-
Number of buys
-
9
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q1 2015
As of 31 Mar 2015,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,414,320 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Broadfin Capital, LLC, SABBY MANAGEMENT, LLC, Candriam Luxembourg S.C.A., GOLDMAN SACHS GROUP INC, BANK HAPOALIM BM, MONETARY MANAGEMENT GROUP INC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), and DEUTSCHE BANK AG\.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.